What Researchers Did
Researchers reviewed the current understanding of the pathophysiology and treatment of osteoradionecrosis of the jaws, including historical theories and emerging therapeutic approaches.
What They Found
The study highlighted a shift from the long-held tissue hypoxia theory, which led to hyperbaric oxygen (HBO) use, to a new theory proposing radiation-induced fibrosis as the primary cause of osteoradionecrosis. New treatments like pentoxifylline and tocopherol, targeting fibrosis and free radical damage, have shown impressive results in reversing the process of osteoradionecrosis.
What This Means for Canadian Patients
Canadian patients with osteoradionecrosis of the jaws may benefit from a re-evaluation of treatment strategies, moving away from unvalidated hyperbaric oxygen therapy towards newer agents. These newer treatments, such as pentoxifylline and tocopherol, could offer more effective options for managing and potentially reversing this debilitating condition.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
This review article primarily discusses theoretical shifts and emerging treatments, indicating a need for further validation and clinical trials to confirm the efficacy of newer agents.